soul trial oral semaglutide cardiovascular outcomes 2025 The impact of on events in patients with type 2 diabetes: review of results from the | Heart Failure Reviews SELECT Trial

Collectively, these findings highlight the dominant importance of circulating levels of semaglutide, irrespective of the route of administration, for the determination of a broad range of clinically meaningful endpoints in people with T2D

It belongs to a class of drugs called GLP-1 receptor agonists, which slow stomach emptying, reduce hunger signals, and help your brain register fullness sooner

Finally, it should be maintained at a dosage of 2.4 mg weekly thereafter

After removing duplicates and screening titles and abstracts, 170 studies were assessed for full-text eligibility

Always consult a qualified healthcare provider before starting any medication, supplement, or weight loss program